BackAvidity Biosciences Overview

Avidity Biosciences Current Cash

Track Avidity Biosciences's current cash ($73M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$72.64M
↓ 70.22% YoYΔ $-171.26M vs prior year quarter

Peer trimmed avg / median

Loading

Avidity Biosciences Current Cash History

Loading

Avidity Biosciences vs. peers: Current Cash Comparison

Loading

Avidity Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Avidity Biosciences (RNA) FAQ

Avidity Biosciences (RNA) currently reports a current cash of $73M as of June 2026. That compares with $240M in the prior-year period — down 70.2% year over year. Use the charts on this page to explore Avidity Biosciences's current cash history and peer comparisons.

Avidity Biosciences's current cash decreased from $240M to $73M — a 70.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Avidity Biosciences reported $73M in current cash as of June 2026. That compares with $240M in the prior-year period — down 70.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $73M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Avidity Biosciences, and consider following RNA for alerts when major investors trade the stock.

Avidity Biosciences is classified in the Healthcare sector. On current cash, it currently shows $73M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RNA with unrelated industries.